PUBLIC LAW 106-310—OCT. 17, 2000 114 STAT. 1153 TITLE XIX—NIH INITIATIVE ON AUTOIMMUNE DISEASES SEC. 1901. AUTOIMMUNE DISEASES; INITIATIVE THROUGH DIRECTOR OF NATIONAL INSTITUTES OF HEALTH. Part B of title IV of the Public Health Service Act (42 U.S.C. 284 et seq.), as amended by section 1001 of this Act, is amended by adding at the end the following: "SEC. 409E. AUTOIMMUNE DISEASES. 42 USC 284i. "(a) EXPANSION, INTENSIFICATION, AND COORDINATION OF ACTIVITIES.— "(1) IN GENERAL. —The Director of NIH shall expand, intensify, and coordinate research and other activities of the National Institutes of Health with respect to autoimmune diseases. "(2) ALLOCATIONS BY DIRECTOR OF NIH. —With respect to amounts appropriated to carry out this section for a fiscal year, the Director of NIH shall allocate the amounts among the national research institutes that are carrying out paragraph (1). "(3) DEFINITION.— The term 'autoimmune disease' includes, for purposes of this section such diseases or disorders with evidence of autoimmune pathogensis as the Secretary determines to be appropriate. " (b) COORDINATING COMMITTEE.— "(1) IN GENERAL.— The Secretary shall ensure that the Autoimmune Diseases Coordinating Committee (referred to in this section as the 'Coordinating Committee') coordinates activities across the National Institutes and with other Federal health programs and activities relating to such diseases. "(2) COMPOSITION. — The Coordinating Committee shall be composed of the directors or their designees of each of the national research institutes involved in research with respect to autoimmune diseases and representatives of all other Federal departments and agencies whose programs involve health functions or responsibilities relevant to such diseases, including the Centers for Disease Control and Prevention and the Food and Drug Administration. " (3) CHAIR. — "(A) IN GENERAL. —With respect to autoimmune diseases, the Chair of the Committee shall serve as the principal advisor to the Secretary, the Assistant Secretary for Health, and the Director of NIH, and shall provide advice to the Director of the Centers for Disease Control and Prevention, the Commissioner of Food and Drugs, and other relevant agencies. "(B) DIRECTOR OF Nin.The Chair of the Committee shall be directly responsible to the Director of NIH. "(c) PLAN FOR NIH ACTIVITIES. — "(1) IN GENERAL.—Not later than 1 year after the date Deadline, of the enactment of this section, the Coordinating Committee shall develop a plan for conducting and supporting research and education on autoimmune diseases through the national research institutes and shall periodically review and revise the plan. The plan shall—
�
